These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

396 related items for PubMed ID: 31734302

  • 1. Pre- Versus Post-Procedure Health Care Resource Utilization in Patients Undergoing Commercial Transcatheter Mitral Valve Repair.
    Rymer JA, Li Z, Cox ML, Bishawi M, Kosinski AS, Cohen DJ, Wang A, Kapadia S, Sorajja P, Carroll JD, Badhwar V, Thourani V, Glower DD, Vemulapalli S.
    JACC Cardiovasc Interv; 2019 Dec 09; 12(23):2416-2426. PubMed ID: 31734302
    [Abstract] [Full Text] [Related]

  • 2. Cardiovascular events and hospital resource utilization pre- and post-transcatheter mitral valve repair in high-surgical risk patients.
    Vemulapalli S, Lippmann SJ, Krucoff M, Hernandez AF, Curtis LH, Foster E, Qasim A, Wang A, Glower DD, Feldman T, Hammill BG.
    Am Heart J; 2017 Jul 09; 189():146-157. PubMed ID: 28625371
    [Abstract] [Full Text] [Related]

  • 3. The Prevalence and Impact of Atrial Fibrillation on 1-Year Outcomes in Patients Undergoing Transcatheter Mitral Valve Repair: Results From the Society of Thoracic Surgeons/American College of Cardiology Transcatheter Valve Therapy Registry.
    Arora S, Vemulapalli S, Stebbins A, Ramm CJ, Kosinski AS, Sorajja P, Piccini JP, Cavender MA, Vavalle JP.
    JACC Cardiovasc Interv; 2019 Mar 25; 12(6):569-578. PubMed ID: 30898255
    [Abstract] [Full Text] [Related]

  • 4. Cost-Effectiveness of Transcatheter Mitral Valve Repair Versus Medical Therapy in Patients With Heart Failure and Secondary Mitral Regurgitation: Results From the COAPT Trial.
    Baron SJ, Wang K, Arnold SV, Magnuson EA, Whisenant B, Brieke A, Rinaldi M, Asgar AW, Lindenfeld J, Abraham WT, Mack MJ, Stone GW, Cohen DJ, COAPT Investigators.
    Circulation; 2019 Dec 03; 140(23):1881-1891. PubMed ID: 31564137
    [Abstract] [Full Text] [Related]

  • 5. Thirty-day readmissions after transcatheter versus surgical mitral valve repair in high-risk patients with mitral regurgitation: Analysis of the 2014-2015 Nationwide readmissions databases.
    Lima FV, Kolte D, Rofeberg V, Molino J, Zhang Z, Elmariah S, Aronow HD, Abbott JD, Ben Assa E, Khera S, Gordon PC, Inglessis I, Palacios IF.
    Catheter Cardiovasc Interv; 2020 Sep 01; 96(3):664-674. PubMed ID: 31868999
    [Abstract] [Full Text] [Related]

  • 6. Mitral Valve Surgical Volume and Transcatheter Mitral Valve Repair Outcomes: Impact of a Proposed Volume Requirement on Geographic Access.
    Vemulapalli S, Prillinger J, Thourani V, Yeh RW.
    J Am Heart Assoc; 2020 Jun 02; 9(11):e016140. PubMed ID: 32456507
    [Abstract] [Full Text] [Related]

  • 7. Combined Mitral and Tricuspid Versus Isolated Mitral Valve Transcatheter Edge-to-Edge Repair in Patients With Symptomatic Valve Regurgitation at High Surgical Risk.
    Besler C, Blazek S, Rommel KP, Noack T, von Roeder M, Luecke C, Seeburger J, Ender J, Borger MA, Linke A, Gutberlet M, Thiele H, Lurz P.
    JACC Cardiovasc Interv; 2018 Jun 25; 11(12):1142-1151. PubMed ID: 29929635
    [Abstract] [Full Text] [Related]

  • 8. Association of Transcatheter Mitral Valve Repair With Quality of Life Outcomes at 30 Days and 1 Year: Analysis of the Transcatheter Valve Therapy Registry.
    Arnold SV, Li Z, Vemulapalli S, Baron SJ, Mack MJ, Kosinski AS, Reynolds MR, Hermiller JB, Rumsfeld JS, Cohen DJ.
    JAMA Cardiol; 2018 Dec 01; 3(12):1151-1159. PubMed ID: 30476950
    [Abstract] [Full Text] [Related]

  • 9. Impact of Transcatheter Mitral Valve Repair on Preprocedural and Postprocedural Hospitalization Rates.
    Czarnecki A, Han L, Abuzeid W, Cantor WJ, Chan V, Cohen EA, Cohen GN, Fam N, Garg P, Hibbert B, Mehta SR, Ong G, Osten M, Ko DT.
    JACC Cardiovasc Interv; 2021 Oct 25; 14(20):2274-2281. PubMed ID: 34674865
    [Abstract] [Full Text] [Related]

  • 10. Transcatheter Mitral Valve Repair in Patients With and Without Cardiac Resynchronization Therapy: The COAPT Trial.
    Kosmidou I, Lindenfeld J, Abraham WT, Kar S, Lim DS, Mishell JM, Whisenant BK, Kipperman RM, Boudoulas KD, Redfors B, Shahim B, Zhang Z, Mack MJ, Stone GW.
    Circ Heart Fail; 2020 Nov 25; 13(11):e007293. PubMed ID: 33176460
    [Abstract] [Full Text] [Related]

  • 11. Impact of Peripheral Artery Disease in Patients With Heart Failure Undergoing Transcatheter Mitral Valve Repair: The COAPT Trial.
    Shahim B, Cohen DJ, Ben-Yehuda O, Redfors B, Kar S, Lim DS, Arnold SV, Li Y, Lindenfeld J, Abraham WT, Mack MJ, Stone GW.
    J Am Heart Assoc; 2023 Feb 21; 12(4):e028444. PubMed ID: 36752227
    [Abstract] [Full Text] [Related]

  • 12. Health Status After Transcatheter Mitral-Valve Repair in Heart Failure and Secondary Mitral Regurgitation: COAPT Trial.
    Arnold SV, Chinnakondepalli KM, Spertus JA, Magnuson EA, Baron SJ, Kar S, Lim DS, Mishell JM, Abraham WT, Lindenfeld JA, Mack MJ, Stone GW, Cohen DJ, COAPT Investigators.
    J Am Coll Cardiol; 2019 May 07; 73(17):2123-2132. PubMed ID: 30894288
    [Abstract] [Full Text] [Related]

  • 13. Transcatheter Mitral Valve Replacement Versus Medical Therapy for Secondary Mitral Regurgitation: A Propensity Score-Matched Comparison.
    Ludwig S, Conradi L, Cohen DJ, Coisne A, Scotti A, Abraham WT, Ben Ali W, Zhou Z, Li Y, Kar S, Duncan A, Lim DS, Adamo M, Redfors B, Muller DWM, Webb JG, Petronio AS, Ruge H, Nickenig G, Sondergaard L, Adam M, Regazzoli D, Garatti A, Schmidt T, Andreas M, Dahle G, Walther T, Kempfert J, Tang GHL, Redwood S, Taramasso M, Praz F, Fam N, Dumonteil N, Obadia JF, von Bardeleben RS, Rudolph TK, Reardon MJ, Metra M, Denti P, Mack MJ, Hausleiter J, Asch FM, Latib A, Lindenfeld J, Modine T, Stone GW, Granada JF, CHOICE-MI and the COAPT Trial Investigators.
    Circ Cardiovasc Interv; 2023 Jun 07; 16(6):e013045. PubMed ID: 37194288
    [Abstract] [Full Text] [Related]

  • 14. Impact of age and comorbidities on the effect of transcatheter versus surgical mitral valve repair on inpatient outcomes.
    Jogu HR, Arora S, Strassle PD, Patel C, Patil N, Venkatesh S, Alkhaimy H, Ramm CJ, Qamar A, Kim SM, Yeung M, Vavalle JP.
    Catheter Cardiovasc Interv; 2020 May 01; 95(6):1195-1201. PubMed ID: 31478339
    [Abstract] [Full Text] [Related]

  • 15. Transcatheter Mitral Valve Repair in Cardiogenic Shock and Mitral Regurgitation: A Patient-Level, Multicenter Analysis.
    Jung RG, Simard T, Kovach C, Flint K, Don C, Di Santo P, Adamo M, Branca L, Valentini F, Benito-González T, Fernández-Vázquez F, Estévez-Loureiro R, Berardini A, Conti N, Rapezzi C, Biagini E, Parlow S, Shorr R, Levi A, Manovel A, Cardenal-Piris R, Diaz Fernandez J, Shuvy M, Haberman D, Sala A, Alkhouli MA, Marini C, Bargagna M, Schiavi D, Denti P, Markovic S, Buzzatti N, Chan V, Hynes M, Mesana T, Labinaz M, Pappalardo F, Taramasso M, Hibbert B.
    JACC Cardiovasc Interv; 2021 Jan 11; 14(1):1-11. PubMed ID: 33069653
    [Abstract] [Full Text] [Related]

  • 16. Management strategies and prognosis of patients ineligible for transcatheter mitral valve replacement.
    Hasan SA, Morsi M, Frakes BS, Bryson ME, Schmidt CW, Seshiah P, Choo J, Smith JM, Answini GA, Stewart-Dehner TL, Yasar SJ, Jollis JG, Berlacher MD, Ratajczak TM, Chung ES, Kereiakes DJ, Garcia S.
    Cardiovasc Revasc Med; 2024 Jul 11; 64():1-4. PubMed ID: 38355340
    [Abstract] [Full Text] [Related]

  • 17. Pulmonary Hypertension in Transcatheter Mitral Valve Repair for Secondary Mitral Regurgitation: The COAPT Trial.
    Ben-Yehuda O, Shahim B, Chen S, Liu M, Redfors B, Hahn RT, Asch FM, Weissman NJ, Medvedofsky D, Puri R, Kapadia S, Sannino A, Grayburn P, Kar S, Lim S, Lindenfeld J, Abraham WT, Mack MJ, Stone GW.
    J Am Coll Cardiol; 2020 Dec 01; 76(22):2595-2606. PubMed ID: 33243380
    [Abstract] [Full Text] [Related]

  • 18. Percutaneous Mitral Valve Repair Vs. Stand-Alone Medical Therapy in Patients with Functional Mitral Regurgitation and Heart Failure.
    Benito-González T, Estévez-Loureiro R, Villablanca PA, Armeni P, Iglesias-Gárriz I, Minguito C, Garrote C, de Prado AP, Tundidor-Sanz E, Gualis J, Fernández-Vázquez F.
    Cardiovasc Revasc Med; 2020 Jan 01; 21(1):52-60. PubMed ID: 31326258
    [Abstract] [Full Text] [Related]

  • 19. Cost-Effectiveness of Mitral Valve Repair Versus Replacement for Severe Ischemic Mitral Regurgitation: A Randomized Clinical Trial From the Cardiothoracic Surgical Trials Network.
    Ferket BS, Ailawadi G, Gelijns AC, Acker M, Hohmann SF, Chang HL, Bouchard, D, Meltzer DO, Michler RE, Moquete EG, Voisine P, Mullen JC, Lala A, Mack MJ, Gillinov AM, Thourani VH, Miller MA, Gammie JS, Parides MK, Bagiella E, Smith RL, Smith PK, Hung JW, Gupta LN, Rose EA, O'Gara PT, Moskowitz AJ, Cardiothoracic Surgical Trials Network (CTSN) Investigators.
    Circ Cardiovasc Qual Outcomes; 2018 Nov 14; 11(11):e004466. PubMed ID: 30785252
    [Abstract] [Full Text] [Related]

  • 20. Comparison of Clinical and Echocardiographic Outcomes After Surgical Redo Mitral Valve Replacement and Transcatheter Mitral Valve-in-Valve Therapy.
    Kamioka N, Babaliaros V, Morse MA, Frisoli T, Lerakis S, Iturbe JM, Binongo J, Corrigan F, Yousef A, Gleason P, Wells JA, Caughron H, Dong A, Rodriguez E, Leshnower B, O'Neill W, Paone G, Eng M, Guyton R, Block PC, Greenbaum A.
    JACC Cardiovasc Interv; 2018 Jun 25; 11(12):1131-1138. PubMed ID: 29929633
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.